Humana's 2027 Star Ratings Jump: 95% of MA Members in 4-Star+ Plans
HUM has more than doubled off its 52-week low of $163.11 on elevated volume (2.1× avg).
Summary
Humana announced its 2027 CMS Star Ratings, with 95% of Medicare Advantage members now in plans rated 4 stars or above, up from prior year. 42% are in 4.5-star plans. The company added 11 more MA contracts rated 4.0+ stars, bringing totals to six 4.5-star and twelve 4.0-star contracts, plus a 4.5-star PDP contract. This follows the 8-K filed this morning confirming the ratings exceeded the Top Quartile goal, supporting the 2028 earnings framework. Higher star ratings directly boost quality bonus payments and member retention, a key driver for Humana's Medicare-heavy revenue base. The AEP enrollment period starts Oct 15, giving the improved ratings immediate commercial impact.
At the time of this announcement, HUM was trading at $444.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $46.5B. The 52-week trading range was $163.11 to $428.88. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.